DDIT3抗体

+ +

•  

   

     Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);    

  
  

•  

   

     Immunofluorescence analysis of MCF-7 cells using DDIT3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)    

  
  

•  

   

     Flow cytometric analysis of MCF-7 cells using DDIT3 mouse mAb (green) and negative control (red).    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human cervical cancer tissues using DDIT3 mouse mAb with DAB staining.    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human rectum cancer tissues using DDIT3 mouse mAb with DAB staining.    

  
  

**Background of DDIT3 Antibody**

The DDIT3 (DNA Damage Inducible Transcript 3) antibody is a crucial tool for detecting the DDIT3 protein, also known as CHOP (CCAAT/enhancer-binding protein homologous protein) or GADD153 (growth arrest and DNA damage-inducible protein 153). DDIT3 is a stress-inducible nuclear protein encoded by the *DDIT3* gene, belonging to the C/EBP family of transcription factors. It is upregulated in response to cellular stressors such as endoplasmic reticulum (ER) stress, DNA damage, oxidative stress, or nutrient deprivation, primarily through the unfolded protein response (UPR) and the integrated stress response (ISR) pathways.

DDIT3 plays a dual role in cellular fate: it promotes apoptosis under prolonged stress by regulating pro-apoptotic genes (e.g., *BIM*, *TRIB3*) while suppressing anti-apoptotic pathways. Its expression is closely associated with pathological conditions, including cancer, neurodegenerative diseases, diabetes, and metabolic disorders. The DDIT3 antibody is widely used in research to investigate ER stress-mediated apoptosis, tumor progression, and mechanisms of diseases linked to proteostatic imbalance.

Available as monoclonal or polyclonal antibodies, DDIT3-specific reagents are validated for techniques like Western blotting, immunohistochemistry, and immunofluorescence. Their specificity ensures accurate detection of DDIT3's ~29 kDa protein, aiding in studies of stress signaling and therapeutic targeting in disease models.